Supplemental Disclosures (Tables)

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of Other Current Assets

Other Current Assets

Other current assets consisted of the following (in thousands):

	March 31, 2024		December 31, 2023
Net cost reimbursement due from collaborators	$	24,526	$	17,745
Accrued interest on investments		1,498		1,551
Other		1,273		1,107
	$	27,297	$	20,403

Schedules of Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31, 2024		December 31, 2023
Accrued external research and development expenses	$	14,508	$	13,762
Accrued personnel costs		8,085		18,146
Accrued sublicense fees and royalties		6,862		14,234
Accrued external general and administrative expenses		2,532		2,717
Accrued purchases of property and equipment		149		386
Other accrued expenses and current liabilities		993		458
	$	33,129	$	49,703